Skip to main content
OpenTrials
Completed

NCT Number: NCT01483495

Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study

The brain is such a metabolically active organ that it consumes about 20% of oxygen burned every minute by an average adult even though it only contributes about 2% of the body weight. As a result, the brain produces a disproportionately high amount of CO2 every minute in comparison with the rest of the body.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UCI Beckman Laser Institute

Irvine, California, 92612, United States

About this study

The researcher can use Diffuse Optical Spectroscopy Imaging, cerebral non-invasive oximetry instrument, to determine cerebrovascular reactivity during surgery procedure. Specifically, the cerebral tissue O2 saturation can measure by Diffuse Optical Spectroscopy Imaging can use for cerebral blood flow in the evaluation of cerebrovascular reactivity.

Adequate brain perfusion is critical not only to supply oxygen and nutrients but also to wash out metabolic end products including CO2. Blood flow depends on perfusion pressure and vascular bed resistance. It is well known that multiple physiological and pathological factors affect cerebral vasculature, and the resistance to blood flow. The cerebrovascular responsiveness to those factors determines how well the brain can maintain and adjust its perfusion.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or Female 20 years of age and older
  • Female non-pregnant
  • Subject scheduled for elective surgery under general anesthesia with intubation.
  • Subject who is able to give informed consent.

Exclusion criteria

  • Less than 20 years old of age
  • Pregnant woman
  • Subjects currently diagnosed with severe hypertension, myocardial ischemic disease, symptomatic valvular disease(s), symptomatic arrhythmia, uncompensated congestive heart failure, intracranial aneurysm.

Treatment and study plan

Diffuse Optical Spectroscopy

Device

Diffuse Optical Spectroscopy Imaging Cerebrovascular Reactivity

Other names: Diffuse Optical Spectroscopy Imaging

Primary outcomes

  1. Brain blood flow

    Time frame: 6 hours

    Optical Imaging assess of Brain blood flow during surgical procedure

Sponsors and collaborators

Lead sponsor

University of California, Irvine

Other

Collaborators

  • Beckman Laser Institute University of California Irvine

Registry information

Official study title

Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry

Acronym: DOSI

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Dec 1, 2011
Registry last updated
Nov 1, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.